- 2023Nature cancer10.1038/s43018-023-00614-y
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
- 2021Science advances10.1126/sciadv.abh0363
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.
- 2021Current opinion in cell biology10.1016/j.ceb.2021.04.007
Quantifying and visualising the nuances of cellular dynamics in vivo using intravital imaging.
- Biochemical Society transactions10.1042/BST20220162
Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy.